Evidence map›Paper›PMID 35720265›Full record

ArticleiScience2022

Identification of a neural development gene expression signature in colon cancer stem cells reveals a role for

Joseph L Regan, Dirk Schumacher, Stephanie Staudte, Andreas Steffen, Ralf Lesche, Joern Toedling, Thibaud Jourdan, Johannes Haybaeck, Nicole Golob-Schwarzl, Dominik Mumberg and 6 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Tumor Innervation: From Bystander to Emerging Therapeutic Target for Cancer.International journal of molecular sciences · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Chromatin Remodeling in Patient-Derived Colorectal Cancer Models.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Joseph L ReganBayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.
Dirk SchumacherLaboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.
Stephanie StaudteBayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.
Andreas SteffenBayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.
Ralf LescheBayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.
Joern ToedlingBayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.
Thibaud JourdanBayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.
Johannes HaybaeckInstitute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Nicole Golob-SchwarzlInstitute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Dominik MumbergBayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.
David HendersonBayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.
Balázs GyőrffyDepartment of Bioinformatics, Semmelweis University, 1094 Budapest, Hungary.
Christian R A RegenbrechtLaboratory of Molecular Tumor Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.
Ulrich KeilholzCharité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.
Reinhold SchäferCharité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.
Martin LangeBayer AG, Research and Development, Pharmaceuticals, 13342 Berlin, Germany.
Bayer (Germany) · DEGerman Cancer Research Center · DENuvisan (Germany) · DEInnsbruck Medical University · ATCharité - Universitätsmedizin Berlin · DESemmelweis University · HUUniversitätsmedizin Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent evidence demonstrates that colon cancer stem cells (CSCs) can generate neurons that synapse with tumor innervating fibers required for tumorigenesis and disease progression. Greater understanding of the mechanisms that regulate CSC driven tumor neurogenesis may therefore lead to more effective treatments. RNA-sequencing analyses of ALDH

Indexed as

CancerStem cells researchTranscriptomics

Identifiers

PMID35720265
PMCPMC9204726
OpenAlexW4281700726

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.